This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Cannabis sativa (hemp)
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Non-psychoactive cannabinoid from hemp with pain and anxiety research.
Non-psychoactive cannabinoid from hemp with pain and anxiety research. Key active compounds include Cannabidiol, CBG trace, CBC trace.
Cannabidiol, along with CBG trace and CBC trace, are the primary bioactive compounds in CBD Source. These compounds modulates NF-κB and COX-2 inflammatory pathways, acts on pain pathways via anti-inflammatory and neuroactive effects.
Analgesic
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anxiolytic
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-epileptic (Epidiolex)
Anti-inflammatory
Pain
Based on traditional use; clinical evidence limited
Epilepsy
Based on traditional use; clinical evidence limited
Anxiety
Based on traditional use; clinical evidence limited
Insomnia
Based on traditional use; clinical evidence limited
Found an error or have a correction for CBD Source?
Report an Issue →